Us2.ai

𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗔𝗺𝘆𝗹𝗼𝗶𝗱𝗼𝘀𝗶𝘀 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝘁 𝗨𝘀𝟮.𝗮𝗶 🚀 Us2.ai is the 𝘰𝘯𝘭𝘺 AI-echo solution enabling fully automated Cardiac Amyloidosis parameter measurements aligned with Guideline Directed Echocardiography Reporting (GDER). Us2.ai achieved FDA clearance for this in June 2024, with additional approvals in Japan and Canada this year. 𝗔𝗻𝗱 𝗻𝗼𝘄 𝘁𝗵𝗲𝗿𝗲 𝗶𝘀 𝗠𝗢𝗥𝗘!💡 Using a single 4-chamber image clip, Us2.ai can now accurately detect amyloidosis on echocardiography. The results have been presented as a late-breaking science at #EuroEcho2024 in Berlin this month. 𝗪𝗮𝗻𝘁 𝘁𝗼 𝘀𝗲𝗲 𝘁𝗵𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀? ➡️ 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝘃𝗶𝗮 𝘁𝗵𝗲 𝗹𝗶𝗻𝗸 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀! Our unique comprehensive solution promises to transform early detection and expand access to guideline-recommended treatments for this underrecognized and underdiagnosed disease. 𝙎𝙩𝙖𝙮 𝙩𝙪𝙣𝙚𝙙 𝙛𝙤𝙧 𝙢𝙤𝙧𝙚 𝙖𝙨 𝙬𝙚 𝙬𝙤𝙧𝙠 𝙩𝙤𝙬𝙖𝙧𝙙 𝙁𝘿𝘼 𝙘𝙡𝙚𝙖𝙧𝙖𝙣𝙘𝙚 𝙛𝙤𝙧 𝙩𝙝𝙞𝙨 𝙘𝙖𝙥𝙖𝙗𝙞𝙡𝙞𝙩𝙮 𝙞𝙣 2025!🌟 #AIinHealthcare #Echocardiography #Innovation #Amyloid #AIEcho #Cardiology #CardiacAmyloidosis #PatientsFirst

Recap of #EACVI day 2: Full action packed booth at Us2.ai ✅ Some clinical training on the booth with Us2.ai users ✅ Awesome presentations: Patricia Pellikka, MD honorary lecture ✅ Bart Bijnens giving a masterclass on #ai in medicine (we need to view all the information on a spectrum of disease) ✅🫶🏻 Anca Elena Bălinișteanu presenting intervendor III study result, very cool! ✅ On my way to complete meeting all the hotshots in #echocardiography: The ever so charming and knowledgeable president of EACVI: Victoria Delgado ✅ The man with all the great ideas (always inspiring me to see things from a different angle): Partho Sengupta ✅ Unexpected but very pleasurable conversation of day 2: Fabian Knebel ✅ Working with my fabulous team: Sabrina Fekecs Nathan Simcox Christine Gouillard #euroecho #euroecho2024

🎉 Exciting News from Us2.ai at #EuroEcho2024! 🎉 📣 Late-Breaking Science at EuroEcho–Imaging 2024 in Berlin! Presenting latest advances in the field of Cardiac Amyloidosis with Us2.ai. Join us from 11-13 December 2024 to explore how our AI innovations are reshaping the diagnosis and monitoring of Cardiac Amyloidosis. These groundbreaking studies showcase the power of Us2.ai to revolutionize patient care. 🌟 You won’t want to miss it! 🌟 Late Breaking Science: A fully automated machine learning algorithm to track disease progression in ATTR-CM 🗣️ Lucia Venneri , MD, PhD, Royal Free Hospital, London (UK) 🗓️ Friday, 13 December 2024 🕒 12:18 PM CET (session starts at 11:30am) 📍 Brahms Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study 🗣️ Adam Ioannou, MBBS, BSc, Royal Free Hospital, London (UK) 🗓️ Friday, 13 December 2024 🕒 12:30 PM CET (session starts at 11:30am) 📍 Brahms #EuroEcho2024 #AIinHealthcare #Echocardiography #CardiovascularInnovation #Cardiology #Echo #AIEcho #Amyloid #LateBreakingScience #CardiacAmyloidosis #PatientsFirst

🚨 Catch Us2.ai on the Road! 🚨 Us2.ai will be attending #EuroEcho2024 in Berlin from 11-13 December! 📍 Find us at Booth B2 Join us for live scanning and an exclusive experience of our cutting-edge AI technology that’s redefining echocardiography. 💡 Discover how our AI-powered solutions can revolutionize your echo workflow and practice: ✔ Consistent, accurate, and faster echocardiogram analysis ✔ Enhanced diagnostic efficiency ✔ The latest innovations in cardiovascular imaging 🌟 Don’t miss this! Late Breaking Science Presentations on Amyloid, showcasing the transformative capabilities of Us2.ai software. A fully automated machine learning algorithm to track disease progression in ATTR-CM 🗣️ Lucia Venneri, MD, PhD, Royal Free Hospital, London (UK) 🗓️ Friday, 13 December 2024 🕒 12:18 PM CET (session starts at 11:30am) 📍 Brahms Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study 🗣️ Adam Ioannou, MBBS, BSc, Royal Free Hospital, London (UK) 🗓️ Friday, 13 December 2024 🕒 12:30 PM CET (session starts at 11:30am) 📍 Brahms See you in Berlin! 👋 Contact us to book a meeting! Christine Gouillard | Nathan Simcox | Yoran M. Hummel | Sabrina Fekecs #AIinHealthcare #Echocardiography #CardiovascularInnovation #Cardiology #Echo #AIEcho #Echocardiography #Amyloid #CardiacAmyloidosis #LateBreakingScience

That’s a wrap on RSNA 2024! What an incredible event filled with meaningful conversations, innovative demos, and inspiring collaborations! Thank you to everyone who stopped by our booth to learn more about Viz.ai, experience live demos, and connect during our Allies in AI Innovation Happy Hour with Us2.ai and Microsoft for Healthcare. During the event, we were thrilled to share our collaboration with Microsoft, if you missed it you can check out the press release here: https://lnkd.in/eAzGYuGa See you next year, Radiological Society of North America (RSNA)!

We can't wait to see you at #RSNA24, booth 4924! Stop by to check out our latest radiology demo or see Us2.ai in action. https://lnkd.in/esqeT6nH

💡 How can digital tools, including AI, revolutionize cardiovascular clinical trials? A recent review published in the European Heart Journal explores the transformative potential of AI and digital tools throughout every stage of clinical trial planning and execution. It also highlights key opportunities for successful integration of these tools into your trials! Ready to take the next step? 🔎 Discover how Us2.ai can be the game-changer for your research! #AIinHealthcare #Cardiology #ClinicalTrials #Innovation #MedicalResearch #DigitalHealth #FutureOfMedicine #Cardiology #AI #Echo #AIEcho #Echocardiography #ClinicalTrials #CardiovascularClinicalTrials

🎯Clearer Images, Smarter Care🎯 One fascinating discovery from the AI-ECHO RCT study was that the quality of echocardiographic images significantly improved with the use of Us2.ai. ‼️This was an unexpected yet valuable result. AI helped sonographers focus more on image acquisition. With AI, sonographers no longer settle for "adequate" images—they strive for the best. From a diagnostic perspective, this improvement in image quality is invaluable, as it enhances the accuracy of echocardiographic interpretation. Share your thoughts on this finding with us below! #Sonographers #AIInHealthcare #EchoInnovation #PatientCare #AIEcho #Cardiology #Echo #Echocardiology #Echocardiogram #ImageQuality

❤️Caring for our Sonographers❤️ Sonographer fatigue is a real issue—but Us2.ai can help! The AI-ECHO RCT shows that using Us2.ai can reduce both the mental and physical fatigue experienced by sonographers, making their work more sustainable and efficient. When your team thrives, so does patient care. Let’s talk about making your practice healthier for everyone with Us2.ai! #SonographersWellbeing #AIInHealthcare #EchoInnovation #PatientCare #AIEcho #Cardiology #Echo #Echocardiology #Echocardiogram #Sonographers